Enoxaparin: all 187 studies that test it
Page 2 of 2. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Timing of VTE Prophylaxis in TBIWithdrawnNCT03081169Phase 4
- Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSIStatus unknownNCT02696330Phase 4
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsCompletedNCT02687204Phase 1
- Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth RestrictionCompletedNCT02672566Phase 3
- Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical TrialCompletedNCT02600260Not applicable
- Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH DoseStatus unknownNCT02486666Phase 3
- : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft SurgeryCompletedNCT02474212Phase 4
- Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®CompletedNCT02444572Phase 4
- The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - StudyCompletedNCT02379806Phase 3
- Prophylaxis of Deep Vein Thrombosis Following Total Hip ArthroplastyCompletedNCT02379663Phase 4
- Timing of Initiation of LMWH Administration in Pregnant Women With APSCompletedNCT02326051Phase 4
- Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)CompletedNCT02325479Phase 1
- Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic PatientsSuspendedNCT02271295Phase 3
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot StudyStatus unknownNCT02260908Not applicable
- Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart ValvesStatus unknownNCT02240927Not applicable
- PK and PD of Single, Escalating Doses of PER977 Following EnoxaparinCompletedNCT02206100Phase 1/2
- A Trial on Efficacy and Safety of Full Dose Tenecteplase Combined With Unfractionated Heparin (UFH) or Enoxaparin in Acute Myocardial Infarction (AMI) in the Prehospital SettingCompletedNCT02181998Phase 3
- Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI)CompletedNCT02181985Phase 3
- Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in StrokeStatus unknownNCT02159287Phase 2
- Enoxamed Study in the Treatment of Acute Coronary SyndromesCompletedNCT02152423Phase 1
- Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized StudyStatus unknownNCT02128178Phase 1/2
- Pharmacokinetics of Enoxaparin in Intensive Care PatientsCompletedNCT02095509Phase 4
- Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.Status unknownNCT02085824Not applicable
- Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.Status unknownNCT01970280Phase 4
- Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid ObesityStatus unknownNCT01970202Phase 4
- Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary ThromboembolismStatus unknownNCT01956955Phase 4
- Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic CancerCompletedNCT01945879Phase 1/2
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedNCT01828697Phase 4
- Anticoagulation With Rivaroxaban in Cardioversion -The ARC StudyCompletedNCT01747746Phase 4
- Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of EnoxaparinCompletedNCT01707732Phase 3
- Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary SyndromeCompletedNCT01687491Phase 4
- Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of LiverWithdrawnNCT01631877Not applicable
- OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)CompletedNCT01589393Not applicable
- Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis PostpartumCompletedNCT01588171Not applicable
- Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac SurgeryWithdrawnNCT01474902Phase 3
- Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancyCompletedNCT01388322Phase 3
- Patients With High-risk Acute Coronary Syndrome Without ST-segment ElevationTerminatedNCT01356992Phase 3
- Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology PatientsSuspendedNCT01356329Phase 3
- Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under EnoxaparinCompletedNCT01354704Phase 4
- Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care PatientsWithdrawnNCT01325779Not applicable
- Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal SurgeryCompletedNCT01308528Phase 3
- Two Weeks of Low Molecular Weight Heparin for Distal Vein ThrombosisStatus unknownNCT01252420Phase 4
- Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver ToxicityCompletedNCT01149304Phase 2
- Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeCompletedNCT01068795Not applicable
- Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin UsersStatus unknownNCT01063426Phase 4
- Taxotere-Enoxaparin-(ENOXA)-StudyTerminatedNCT01058759Phase 3
- Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe PreeclampsiaCompletedNCT00986765Phase 3
- Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract SurgeryCompletedNCT00986076Phase 4
- Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual AbortionCompletedNCT00959621Phase 3
- A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)WithdrawnNCT00916669Phase 2
- Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical PatientsCompletedNCT00894283Early Phase 1
- The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-studyCompletedNCT00882635Phase 3
- Enoxaparin as Treatment for VulvodyniaCompletedNCT00874484Phase 2
- Tirofiban and Enoxaparin in High Risk Coronary InterventionCompletedNCT00790387Phase 4
- Chemotherapy With or Without Enoxaparin in Pancreatic CancerCompletedNCT00785421Phase 2/3
- Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)CompletedNCT00771563Phase 3
- Anticoagulation Post Laparoscopic SplenectomyTerminatedNCT00769873Phase 2
- Prevention of Unexplained Recurrent Abortion by EnoxaparineTerminatedNCT00740545Phase 3
- Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgeryCompletedNCT00723216Phase 3
- STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH)CompletedNCT00718471Phase 3
- Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CTCompletedNCT00718354Phase 3
- Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral HemorrhageStatus unknownNCT00699465Phase 4
- Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture SurgeryCompletedNCT00685958Phase 3
- Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving EnoxaparinCompletedNCT00622648Phase 4
- Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)CompletedNCT00622115Phase 1
- Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)TerminatedNCT00518245Phase 4
- Thromboprophylaxis and Bariatric SurgeryStatus unknownNCT00444652Phase 4
- Enoxaparin Versus Unfractionated Heparin in PCICompletedNCT00439855Phase 4
- Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac SurgeryCompletedNCT00420667Not applicable
- An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging StudyCompletedNCT00402467Phase 2
- Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer PatientsCompletedNCT00375076Phase 3
- The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill PatientsCompletedNCT00351663Phase 4
- Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)CompletedNCT00349180Phase 3
- HENOX: Enoxaparine in HemodialysisCompletedNCT00347490Phase 4
- ARIXTRA Local Study For Registration In China.CompletedNCT00328939Phase 3
- LV Thrombus Pilot Study for Comparing Enoxaparin Vs. WarfarinCompletedNCT00321009Not applicable
- ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve ReplacementCompletedNCT00298285Phase 4
- Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)CompletedNCT00289042Phase 4
- Enoxaparin in Acute Venous Thromboembolic DiseaseCompletedNCT00265993Phase 4
- The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.TerminatedNCT00232271Phase 4
- The Use of Low Molecular Weight Heparin in Traumatic Brain InjuryCompletedNCT00170378Phase 4
- Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)CompletedNCT00077844Phase 2/3
- Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)CompletedNCT00077818Phase 4
- PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNCT00077805Phase 4
- Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)CompletedNCT00077792Phase 3
- EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNCT00077753Phase 4
- SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary SyndromesCompletedNCT00043784Phase 3